# TRETINOIN
> **ANDA202209** · Abbreviated New Drug Application (Generic) · Sponsor: ALLERGAN · Approved 2012-10-11
## Drug
- **FDA Application Number:** ANDA202209
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TRETINOIN
- **Generic name:** Tretinoin
- **Active ingredients:** TRETINOIN
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Discontinued
- **Sponsor:** ALLERGAN
- **First approval:** 2012-10-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202209)
---
*AI Analytics · CC0 1.0*